Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal…
Atossa Therapeutics Inc (NASDAQ: ATOS) Granted Regulatory Approval To Open Clinical…
Sorrento Therapeutics Inc (NASDAQ: SRNE), Receives FDA Nod For Clinical Study…
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed…
Galectin Therapeutics Inc. (NASDAQ: GALT) Announces Results From Phase 1b Clinical…
Finance
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:MBRX
Tag: NASDAQ:MBRX
Moleculin Biotech Inc. (NASDAQ:MBRX) Granted Three Rare Paediatric Disease Designations For...
Ward Sport
-
December 4, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Receives Rare Paediatric Disease Designation For WP1066...
Matt Wade
-
December 3, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma...
Gavins Felicity
-
July 23, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...
Kate Hudson
-
June 15, 2020
0
.td-post-views{ display: none !important; }
